Cargando…
Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators
BACKGROUND: Therapeutic response in infectious disease involves host as well as microbial determinants. Because the immune and inflammatory response to Leishmania (Viannia) species defines the outcome of infection and efficacy of treatment, immunomodulation is considered a promising therapeutic stra...
Autores principales: | Gonzalez-Fajardo, Laura, Fernández, Olga Lucía, McMahon-Pratt, Diane, Saravia, Nancy Gore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449175/ https://www.ncbi.nlm.nih.gov/pubmed/26024228 http://dx.doi.org/10.1371/journal.pntd.0003820 |
Ejemplares similares
-
CD4 T cell activation by B cells in human Leishmania (Viannia) infection
por: Rodriguez-Pinto, Daniel, et al.
Publicado: (2014) -
The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
por: Lamotte, Suzanne, et al.
Publicado: (2017) -
In vivo antileishmanial activity of Annona
mucosa extracts
por: de Lima, Janaína Paolucci Sales, et al.
Publicado: (2020) -
The interplay of helminthic neuropeptides and proteases in parasite survival and host immunomodulation
por: Kaur, Rimanpreet, et al.
Publicado: (2022) -
ACW-02 an Acridine Triazolidine Derivative Presents Antileishmanial Activity Mediated by DNA Interaction and Immunomodulation
por: Albino, Sonaly Lima, et al.
Publicado: (2023)